Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02868632
What this trial is testing

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health
Not applicableUnknownNCT04082455
What this trial is testing

Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
Shanghai Proton and Heavy Ion Center 49
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT01834170
What this trial is testing

EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
University of Tehran 12
Testing effectiveness (Phase 2)Study completedNCT01397019
What this trial is testing

Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 56
Testing effectiveness (Phase 2)UnknownNCT00346281
What this trial is testing

32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
pSiMedica Limited 15
Not applicableLooking for participantsNCT05298722
What this trial is testing

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

Who this might be right for
Pancreatic Cancer
University Hospital, Ghent 45
Testing effectiveness (Phase 2)UnknownNCT01867892
What this trial is testing

A Phase II Study of Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Health Research Institutes, Taiwan 86
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Early research (Phase 1)Study completedNCT00789763
What this trial is testing

Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 12
Testing effectiveness (Phase 2)Ended earlyNCT01318642
What this trial is testing

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the PancreasLocally AdvancedUnresectable
NantBioScience, Inc. 10
Early research (Phase 1)Study completedNCT01068327
What this trial is testing

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage III Pancreatic Cancer
University of Nebraska 46
Not applicableEnded earlyNCT04136769
What this trial is testing

Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Ulrich Ronellenfitsch, MD 3
Not applicableStudy completedNCT06195254
What this trial is testing

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

Who this might be right for
Stereotactic Body RadiotherapyPD-1 InhibitorsPancreatic Cancer
Peking University Third Hospital 19
Testing effectiveness (Phase 2)UnknownNCT00006117
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT03040986
What this trial is testing

Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations

Who this might be right for
KRAS NP_004976.2:p.G12RStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 8
Large-scale testing (Phase 3)Study completedNCT00088894
What this trial is testing

Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 590
Early research (Phase 1)UnknownNCT06094777
What this trial is testing

HY-0102 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT03443492
What this trial is testing

SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
National Health Research Institutes, Taiwan 130
Early research (Phase 1)Ended earlyNCT01739439
What this trial is testing

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IIB Pancreatic Cancer+1 more
Fox Chase Cancer Center 6
Next Page